Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Gary Mohilner who wrote (83614)	9/17/2000 11:22:30 AM
From: Knighty Tin	Respond to of 132070

Gary, I certainly like Immunogen's future, though I chose Protein Design as my horse in this race. However, there seems to be room for both. I preferred PDLI due to the fact that Immunogen was once one of my all time great put stocks and management blew it bigtime early this decade, to my profit. However, what they are doing now is much more promising. I also chose PDLI due to the fact that they are based in my home town of Fremont and I have many more, closer sources there than I have in Cambridge. You certainly deserve congrats for this 1000%er. Biotech stocks are like that. You sweat over one for awhile and then they zoom or die. Big deal. If you have a diversified list, the 1000%ers more than make up for the dying swans.